Pluristem developing off-the-shelf cell therapy to cure blood cancers and treat radiation sickness Print E-mail
By Sharon di Stefano   
Wednesday, 05 November 2014 08:04
Innovation is the root of  Pluristem Therapeutics’s (PSTI:NASDAQ) technology, and its latest offering, PLX-RAD cells represent a new line of allogenic off-the-shelf therapy with two distinct and vital applications – bone marrow transplant (BMT) and acute radiation syndrome (ARS).
Read more...
 
A Novel Therapy for the Treatment of Knee Osteoarthritis Print E-mail
By Josh Gee   
Monday, 03 November 2014 09:00
A novel therapy for the treatment of knee osteoarthritis from Cellular Biomedicine Group.
Read more...
 
Nektar Presents Positive Preclinical Data on Kappa Agonist Molecules; Cannabis Kinetics Outlines Mission Statement and Growth Opportunities Print E-mail
By Josh Gee   
Friday, 19 September 2014 18:52
Below is a look at some of the headlines for companies that made news in the healthcare sector on September 19, 2014.
Read more...
 
Delcath Systems, Marrone Bio Innovations, Rexahn Pharmaceuticals, Cleveland BioLabs, Repros Therapeutics Print E-mail
By Peter Depalma   
Wednesday, 03 September 2014 13:51
U.S. stocks jumped on Wednesday, with the S&P 500 hitting another record high on hopes that a resolution would be reached between Ukraine and Russia and data showing manufacturing activity continues to strengthen.
Read more...
 
Neptune, Amgen, Cancer Genetics, StemCells, Delcath Systems Print E-mail
By Staff and Wire Reports   
Wednesday, 02 October 2013 13:56
U.S. stocks fell on Wednesday as a partial U.S. government shutdown entered its second day and data showed private employers added fewer jobs than expected in September.
Read more...
 
Clovis Oncology Skyrockets After ASCO Presentations Print E-mail
By Brian Wilson - Lead Contributor   
Tuesday, 04 June 2013 08:53
Clovis is an acquisition-focused biopharmaceutical company that stayed under the radar after its NASDAQ IPO in November 2011.
Read more...
 
TESARO Inc, Nektar Therapeutics, Clovis Oncology Inc, Curis, Synta Pharmaceuticals Print E-mail
By Staff and Wire Reports   
Monday, 03 June 2013 12:43
U.S. stock benchmarks were mixed to start the month, but largely shrugged off sharp losses from the previous session and continued volatility in Japanese stocks.
Read more...
 
Delcath Systems, Chemed Corporation, Regeneron Pharmaceuticals, Arena Pharmaceuticals, Genetic Technologies Print E-mail
By Staff and Wire Reports   
Friday, 03 May 2013 12:55
U.S. stocks rallied on Friday, with the S&P 500 and Dow industrials hitting intraday records after employment grew more than expected in April, easing concerns about a weak economy.
Read more...
 
Geron Corporation, Arrowhead Research, Spectrum Pharmaceuticals, Delcath Systems, Cerus Corporation Print E-mail
By Staff and Wire Reports   
Thursday, 14 March 2013 14:41
Stocks rose on Thursday as the Dow extended its recent winning streak to 10 days and the S&P 500 closed in on a record high as investors were encouraged by data that showed the labor market's recovery was gaining traction.
Read more...
 
Humana Inc, MediciNova, VIVUS, AstraZeneca plc, Tenet Healthcare Corporation Print E-mail
By Staff and Wire Reports   
Tuesday, 26 February 2013 15:06
Stocks advanced on Tuesday after Federal Reserve Chairman Ben Bernanke defended the Fed's bond-buying stimulus before Congress, but he warned forced spending cuts that could be triggered this week represented a headwind for the economy.
Read more...
 
<< Start < Prev 11 12 Next > End >>

Page 11 of 12

Newsletter